α1-antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α

Angelia Lockett, Samuel Kimani, Godfrey Ddungu, Sabine Wrenger, Rubin M. Tuder, Sabina M. Janciauskiene, Irina Petrache

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

α1-Antitrypsin (A1AT) is an acute-phase reactant, but also a major protective factor against the development of chronic obstructive pulmonary disease, a complex disease with sustained chronic inflammation. The lung-protective effects of A1AT have been attributed to the inhibition of proteases involved in lung matrix fragmentation, macrophage activation, and endothelial-cell apoptosis. More recently, A1AT has been shown to directly interact with or modulate the actions of cytokines such as TNF-α or IL-1 in inflammatory cells, but its effect on the lung endothelium, an active participant in the amplification and resolution of inflammation, has received little attention. An important role of A1AT in modulating lung endothelial inflammatory responses is expected, given the high concentrations of circulating A1AT during inflammation and its active uptake by endothelial cells. We investigated the role of A1AT in primary lung microvascular endothelial cell activation by relevant cytokines such as TNF-α or IL-1b. Despite an initial marked augmentation of TNF-α self-induced transcription, A1AT inhibited TNF-α receptor 1 up-regulation and significantly reduced TNF-α secretion, effects that were associated with inhibition of TNF-α-converting enzyme activity. Furthermore, A1AT inhibited calpain activity, whose activationby TNF-αcontributedto decreased intracellularA1ATconcentrations. These data indicate that A1AT initially facilitates acute responses of the endothelium to TNF-α, followed by selective inhibition of TNF-α-induced-self amplification, which may assist the vasculature in the resolution of chronic inflammation.

Original languageEnglish
Pages (from-to)143-150
Number of pages8
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume49
Issue number1
DOIs
StatePublished - Jul 2013

Fingerprint

Endothelial cells
Endothelial Cells
Lung
Amplification
Inflammation
Chemical activation
Cytokines
Enzyme inhibition
Pulmonary diseases
Calpain
Acute-Phase Proteins
Macrophages
Tumor Necrosis Factor Receptors
Enzyme activity
Endothelium
Transcription
Interleukin-1
Peptide Hydrolases
Macrophage Activation
Apoptosis

Keywords

  • COPD
  • Inflammation
  • Proteinase inhibitor
  • Serpin
  • Vascular

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

α1-antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α. / Lockett, Angelia; Kimani, Samuel; Ddungu, Godfrey; Wrenger, Sabine; Tuder, Rubin M.; Janciauskiene, Sabina M.; Petrache, Irina.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 49, No. 1, 07.2013, p. 143-150.

Research output: Contribution to journalArticle

Lockett, Angelia ; Kimani, Samuel ; Ddungu, Godfrey ; Wrenger, Sabine ; Tuder, Rubin M. ; Janciauskiene, Sabina M. ; Petrache, Irina. / α1-antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α. In: American Journal of Respiratory Cell and Molecular Biology. 2013 ; Vol. 49, No. 1. pp. 143-150.
@article{4577f2a09011408ea630643c6ac79565,
title = "α1-antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α",
abstract = "α1-Antitrypsin (A1AT) is an acute-phase reactant, but also a major protective factor against the development of chronic obstructive pulmonary disease, a complex disease with sustained chronic inflammation. The lung-protective effects of A1AT have been attributed to the inhibition of proteases involved in lung matrix fragmentation, macrophage activation, and endothelial-cell apoptosis. More recently, A1AT has been shown to directly interact with or modulate the actions of cytokines such as TNF-α or IL-1 in inflammatory cells, but its effect on the lung endothelium, an active participant in the amplification and resolution of inflammation, has received little attention. An important role of A1AT in modulating lung endothelial inflammatory responses is expected, given the high concentrations of circulating A1AT during inflammation and its active uptake by endothelial cells. We investigated the role of A1AT in primary lung microvascular endothelial cell activation by relevant cytokines such as TNF-α or IL-1b. Despite an initial marked augmentation of TNF-α self-induced transcription, A1AT inhibited TNF-α receptor 1 up-regulation and significantly reduced TNF-α secretion, effects that were associated with inhibition of TNF-α-converting enzyme activity. Furthermore, A1AT inhibited calpain activity, whose activationby TNF-αcontributedto decreased intracellularA1ATconcentrations. These data indicate that A1AT initially facilitates acute responses of the endothelium to TNF-α, followed by selective inhibition of TNF-α-induced-self amplification, which may assist the vasculature in the resolution of chronic inflammation.",
keywords = "COPD, Inflammation, Proteinase inhibitor, Serpin, Vascular",
author = "Angelia Lockett and Samuel Kimani and Godfrey Ddungu and Sabine Wrenger and Tuder, {Rubin M.} and Janciauskiene, {Sabina M.} and Irina Petrache",
year = "2013",
month = "7",
doi = "10.1165/rcmb.2012-0515OC",
language = "English",
volume = "49",
pages = "143--150",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - α1-antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α

AU - Lockett, Angelia

AU - Kimani, Samuel

AU - Ddungu, Godfrey

AU - Wrenger, Sabine

AU - Tuder, Rubin M.

AU - Janciauskiene, Sabina M.

AU - Petrache, Irina

PY - 2013/7

Y1 - 2013/7

N2 - α1-Antitrypsin (A1AT) is an acute-phase reactant, but also a major protective factor against the development of chronic obstructive pulmonary disease, a complex disease with sustained chronic inflammation. The lung-protective effects of A1AT have been attributed to the inhibition of proteases involved in lung matrix fragmentation, macrophage activation, and endothelial-cell apoptosis. More recently, A1AT has been shown to directly interact with or modulate the actions of cytokines such as TNF-α or IL-1 in inflammatory cells, but its effect on the lung endothelium, an active participant in the amplification and resolution of inflammation, has received little attention. An important role of A1AT in modulating lung endothelial inflammatory responses is expected, given the high concentrations of circulating A1AT during inflammation and its active uptake by endothelial cells. We investigated the role of A1AT in primary lung microvascular endothelial cell activation by relevant cytokines such as TNF-α or IL-1b. Despite an initial marked augmentation of TNF-α self-induced transcription, A1AT inhibited TNF-α receptor 1 up-regulation and significantly reduced TNF-α secretion, effects that were associated with inhibition of TNF-α-converting enzyme activity. Furthermore, A1AT inhibited calpain activity, whose activationby TNF-αcontributedto decreased intracellularA1ATconcentrations. These data indicate that A1AT initially facilitates acute responses of the endothelium to TNF-α, followed by selective inhibition of TNF-α-induced-self amplification, which may assist the vasculature in the resolution of chronic inflammation.

AB - α1-Antitrypsin (A1AT) is an acute-phase reactant, but also a major protective factor against the development of chronic obstructive pulmonary disease, a complex disease with sustained chronic inflammation. The lung-protective effects of A1AT have been attributed to the inhibition of proteases involved in lung matrix fragmentation, macrophage activation, and endothelial-cell apoptosis. More recently, A1AT has been shown to directly interact with or modulate the actions of cytokines such as TNF-α or IL-1 in inflammatory cells, but its effect on the lung endothelium, an active participant in the amplification and resolution of inflammation, has received little attention. An important role of A1AT in modulating lung endothelial inflammatory responses is expected, given the high concentrations of circulating A1AT during inflammation and its active uptake by endothelial cells. We investigated the role of A1AT in primary lung microvascular endothelial cell activation by relevant cytokines such as TNF-α or IL-1b. Despite an initial marked augmentation of TNF-α self-induced transcription, A1AT inhibited TNF-α receptor 1 up-regulation and significantly reduced TNF-α secretion, effects that were associated with inhibition of TNF-α-converting enzyme activity. Furthermore, A1AT inhibited calpain activity, whose activationby TNF-αcontributedto decreased intracellularA1ATconcentrations. These data indicate that A1AT initially facilitates acute responses of the endothelium to TNF-α, followed by selective inhibition of TNF-α-induced-self amplification, which may assist the vasculature in the resolution of chronic inflammation.

KW - COPD

KW - Inflammation

KW - Proteinase inhibitor

KW - Serpin

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=84883190759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883190759&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2012-0515OC

DO - 10.1165/rcmb.2012-0515OC

M3 - Article

C2 - 23526215

AN - SCOPUS:84883190759

VL - 49

SP - 143

EP - 150

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 1

ER -